Document is current

Article History

Received: 3 March 2021

Accepted: 28 March 2021

First Online: 7 April 2021

Declarations

:

: Not applicable.

: Not applicable.

: Paolo A. Ascierto (PAA): <i>Consulting fee</i>: BMS, Roche, Array, Novartis, Merck Serono, Pierre Fabre, Incyte, Newlinks Genetics, Genmab, Medimmune, Sindax, AstraZeneca, Sun Pharma, Sanofi, Idera, Ultimovacs, Sandox, Immunocore, 4SC, Alkermes, Italfarmaco, Nektar, Boehringer-Ingelheim, Eisai, Regeneron, Daiichi Sankyo, Pfizer, Oncosec, Nouscom, Takis, Lunaphore. <i>Contracted Research:</i> BMS, Roche, Array. <i>Travel Support</i>: MSD. Joshua Brody (JB): no conflict to disclose. Lisa H. Butterfield (LHB): declares the following unrelated advisory activities: StemImmune/Calidi Scientific and Medical Advisory Board, April 6, 2017-present; SapVax Advisory Board meetings Nov. 15, 2017; Dec. 6, 2018; NextCure, Scientific Advisory Board, 2018–2020; Western Oncolytics, Scientific Advisory Board, 2018-present; Torque Therapeutics, Scientific Advisory Board, 2018–2020; Khloris, Scientific Advisory Board, 2019-present; Pyxis, Scientific Advisory Board, 2019-present; Cytomix, Scientific Advisory Board, 2019-present; Vir, Scientific Advisory Board meeting, Feb. 2020; DCprime, Scientific Advisory Board meeting, Nov. 2020; RAPT, Scientific Advisory Board, 2020-present. Olivera J. Finn (OJF): is member of the External Advisory Boards of Biovelocita, Immodulon, GeoVax, PDS Biotech and Iaso Biotherapeutics. John Goldberg (JG): full-time employee of Oncorus Inc. Francesco Perrone (FP): Advisory role or speaker activities Pharmaceutical industries: Bayer, Janssen Cilag, Pierre Fabre, Astra Zeneca, Celgene, Incyte, Sandoz, Bristol Myers Squibb, Ipsen, Eli Lilly. Academic Institutions: Cerismas, SIFO, ALTEMS, Humanitas, SMA, UniMoRe, Bocconi, AIOT, Campus Biomedico. Institutional financial interests, for financial support to research activities: Astra Zeneca, Bayer, Roche, Merck, Pfizer, Incyte, Sanofi, BioClin, Tesaro. Ryan J. Sullivan (RJS): Consulting/Advisory Board Participant—Asana Biosciences, AstraZaneca, Bristol Myers Squibb, Eisai, Iovance, Merck, Novartis, Pfizer, OncoSec, Replimune; Contracted Research—Merck, Amgen. Bernard A. Fox (BAF): Scientific Advisory Board (Advising/Consulting/Stock): Akoya/PerkinElmer, AstraZeneca / MedImmune, Bayer, Bristol-Myers Squibb, CellDex Therapeutics, Definiens, Incyte, Janssen /Johnson & Johnson, Macrogenics, PrimeVax—stock, Turnstone, UbiVac—Co founder/CEO/stock, Ultivue—Research Support: Akoya/PerkinElmer, Bayer, Bristol-Myers Squibb, Definiens, Janssen / Johnson & Johnson, Macrogenics, MedImmune/AstraZeneca, NanoString, OncoSec, Quanterix, Shimadzu, Ventana/Roche, Viralytics/Merck. Patrick Hwu (PH): Scientific Advisory Board: Immatics US, Inc., Dragonfly, GlaxoSmithKline, Sanofi Pasteur. Igor Puzanov (IP): Amgen-consultant fees, steering committee member KEYNOTE 265; Merck-advisory board fees; Sotio-consultant fees; Celldex-private stock ownership. <i>Institutional Clinical Trial Support:</i> Nektar, Idera, Oncosec, Amgen, Rgenix, Immunocore, Dynavax.